van der Luijt RB - Search Results

1

Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.

Gracanin A, Dreijerink KM, van der Luijt RB, Lips CJ, Höppener JW. Gracanin A, et al. Among authors: van der luijt rb. Cancer Res. 2009 Aug 15;69(16):6371-4. doi: 10.1158/0008-5472.CAN-09-0678. Epub 2009 Aug 4. Cancer Res. 2009. PMID: 19654304 Review.

2

Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers.

Pijpe A, Mulder RL, Manders P; HEBON; van Leeuwen FE, Rookus MA. Pijpe A, et al. J Clin Epidemiol. 2011 Dec;64(12):1434-43. doi: 10.1016/j.jclinepi.2011.04.005. Epub 2011 Jul 20. J Clin Epidemiol. 2011. PMID: 21764559

3

Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding.

Roijers JF, de Wit MJ, van der Luijt RB, Ploos van Amstel HK, Höppener JW, Lips CJ. Roijers JF, et al. Among authors: van der luijt rb. Eur J Clin Invest. 2000 Jun;30(6):487-92. doi: 10.1046/j.1365-2362.2000.00664.x. Eur J Clin Invest. 2000. PMID: 10849016

4

Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.

Hes FJ, McKee S, Taphoorn MJ, Rehal P, van Der Luijt RB, McMahon R, van Der Smagt JJ, Dow D, Zewald RA, Whittaker J, Lips CJ, MacDonald F, Pearson PL, Maher ER. Hes FJ, et al. Among authors: van der smagt jj, van der luijt rb. J Med Genet. 2000 Dec;37(12):939-43. doi: 10.1136/jmg.37.12.939. J Med Genet. 2000. PMID: 11106358 Free PMC article.

5

[Multiple endocrine neoplasia type 1: recent developments and guidelines for DNA diagnosis and periodic clinical monitoring].

Dreijerink KM, Roijers JF, van der Luijt RB, Höppener JW, Lips CJ. Dreijerink KM, et al. Among authors: van der luijt rb. Ned Tijdschr Geneeskd. 2000 Dec 16;144(51):2445-9. Ned Tijdschr Geneeskd. 2000. PMID: 11151652 Review. Dutch.

6

Clinical management of Von Hippel-Lindau (VHL) disease.

Hes FJ, van der Luijt RB, Lips CJ. Hes FJ, et al. Among authors: van der luijt rb. Neth J Med. 2001 Nov;59(5):225-34. doi: 10.1016/s0300-2977(01)00165-6. Neth J Med. 2001. PMID: 11705642 Review.

7

Molecular genetic aspects of Von Hippel-Lindau (VHL) disease and criteria for DNA analysis in subjects at risk.

Hes FJ, Lips CJ, van der Luijt RB. Hes FJ, et al. Among authors: van der luijt rb. Neth J Med. 2001 Nov;59(5):235-43. doi: 10.1016/s0300-2977(01)00164-4. Neth J Med. 2001. PMID: 11705643 Review.

8

[From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].

Hofstra RM, van der Luijt RB, Lips CJ. Hofstra RM, et al. Among authors: van der luijt rb. Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2217-21. Ned Tijdschr Geneeskd. 2001. PMID: 11757244 Review. Dutch.

9

Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918.

Menko FH, van der Luijt RB, de Valk IA, Toorians AW, Sepers JM, van Diest PJ, Lips CJ. Menko FH, et al. Among authors: van diest pj, van der luijt rb. J Clin Endocrinol Metab. 2002 Jan;87(1):393-7. doi: 10.1210/jcem.87.1.8136. J Clin Endocrinol Metab. 2002. PMID: 11788682

10

Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening?

Geerdink EA, Van der Luijt RB, Lips CJ. Geerdink EA, et al. Among authors: van der luijt rb. Eur J Endocrinol. 2003 Dec;149(6):577-82. doi: 10.1530/eje.0.1490577. Eur J Endocrinol. 2003. PMID: 14641000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page